These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Carcinogenicity of anticancer drugs and especially alkylating agents. Schmähl D IARC Sci Publ; 1986; (78):29-35. PubMed ID: 3583394 [No Abstract] [Full Text] [Related]
7. Delayed consequences of cancer therapy: proven and potential. Basic mechanisms. Cancer; 1976 Feb; 37(2 Suppl):999-1013. PubMed ID: 1253134 [No Abstract] [Full Text] [Related]
8. [The cancerogenicity of antineoplastic agents]. Rieche K Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118 [No Abstract] [Full Text] [Related]
9. [The effect of antineoplastic alkylating agents on the serum protein fraction of rats with sarcoma 45]. Kulik GI; Pel'kis FP Vopr Onkol; 1969; 15(7):68-71. PubMed ID: 4980425 [No Abstract] [Full Text] [Related]
10. [Side-effects of cytostatic and immunosuppressive therapy]. Hartwich G Fortschr Med; 1973 Mar; 91(9):357-62. PubMed ID: 4633019 [No Abstract] [Full Text] [Related]
11. Carcinogenicity of alkylating cytostatic drugs. Proceedings of a symposium. Heidelberg, Federal Republic of Germany, 25-27 November 1985. IARC Sci Publ; 1986; (78):1-338. PubMed ID: 3583383 [No Abstract] [Full Text] [Related]
12. [Carcinogenicity of anticancer agents]. Hayashi Y; Takahashi M; Yoshimura H Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866 [TBL] [Abstract][Full Text] [Related]
13. Delayed cross-reactivity between cyclophosphamide and chlorambucil. Ben Fredj N; Aouam K; Chaabane A; Njim L; Boughattas N J Clin Pharmacol; 2012 May; 52(5):771-4. PubMed ID: 21956606 [No Abstract] [Full Text] [Related]
15. Gynecologic aspects of malignancies following immunosuppressive or cytotoxic therapy. Deppe G Prog Clin Biol Res; 1981; 70():375-8. PubMed ID: 7031697 [No Abstract] [Full Text] [Related]
16. Carcinogenic action of anticancer drugs with special reference to immunosuppression. Schmähl D Cancer; 1977 Oct; 40(4 Suppl):1927-9. PubMed ID: 332335 [TBL] [Abstract][Full Text] [Related]
17. Review of the potential effects of three commonly used antineoplastic and immunosuppressive drugs (cyclophosphamide, azathioprine, doxorubicin on the embryo and placenta). Matalon ST; Ornoy A; Lishner M Reprod Toxicol; 2004; 18(2):219-30. PubMed ID: 15019720 [No Abstract] [Full Text] [Related]
18. The risk of adjuvant chemotherapy. Gürtler R Arch Geschwulstforsch; 1978; 48(7):644-52. PubMed ID: 736745 [No Abstract] [Full Text] [Related]
19. [On ways of reducing the toxic effects of antitumorous preparations]. Monakhov BV Vopr Onkol; 1968; 14(8):101-12. PubMed ID: 4301862 [No Abstract] [Full Text] [Related]